Switch to:
More From Other Websites
Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing Apr 28 2017
UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21) Apr 28 2017
[$$] Wall Street’s New Problem: When Fund Titans Invest on the Side Apr 26 2017
Hedge fund billionaire Bill Ackman provides a perfect example of how the rich get richer Apr 26 2017
Morning Movers: Valeant Jumps, Boeing Drops, Seagate Tumbles Apr 26 2017
Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic,... Apr 26 2017
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around? Apr 25 2017
Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club Apr 24 2017
Blog Coverage: Valeant Announces the Pricing for SILIQ as the Lowest Priced Injectable Biologic for... Apr 24 2017
The Scariest Prescription Drug Price Chart You'll Ever See Apr 23 2017
Why Now Is Not the Time to Buy Valeant Pharmaceuticals Apr 22 2017
Valeant Shares Plummet as Debt Issues Remain Unsolved, Prices New Psoriasis Drug Apr 21 2017
Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today Apr 21 2017
1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines' Oscar... Apr 21 2017
Valeant Pharmaceuticals: Not Worth the Risk! Apr 21 2017
Jim Cramer -- Valeant's Not Worth the Speculation Apr 21 2017
Valeant prices psoriasis treatment at $3,500 per month Apr 21 2017
Valeant says its plaque psoriasis drug will cost $3,500 a month Apr 21 2017
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The... Apr 21 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK